HSBC Holdings’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.73M Sell
505,580
-8,829
-2% -$174K 0.01% 937
2025
Q4
$9.74M Buy
514,409
+84,784
+20% +$1.57M 0.01% 965
2025
Q3
$8.02M Buy
429,625
+216,709
+102% +$4.05M ﹤0.01% 1008
2025
Q2
$3.92M Sell
212,916
-190,367
-47% -$3.38M ﹤0.01% 1241
2025
Q1
$7.06M Buy
403,283
+125,211
+45% +$2.11M ﹤0.01% 999
2024
Q4
$4.8M Sell
278,072
-28,165
-9% -$514K ﹤0.01% 1148
2024
Q3
$5.69M Buy
306,237
+8,817
+3% +$149K ﹤0.01% 1082
2024
Q2
$4.57M Buy
297,420
+47,473
+19% +$678K ﹤0.01% 1086
2024
Q1
$3.69M Buy
249,947
+123,949
+98% +$1.72M ﹤0.01% 1211
2023
Q4
$1.8M Buy
125,998
+16,525
+15% +$235K ﹤0.01% 1534
2023
Q3
$1.53M Sell
109,473
-17,779
-14% -$227K ﹤0.01% 1560
2023
Q2
$1.5M Buy
127,252
+10,327
+9% +$118K ﹤0.01% 1555
2023
Q1
$1.34M Buy
116,925
+16,766
+17% +$207K ﹤0.01% 1660
2022
Q4
$1.24M Sell
100,159
-6,914
-6% -$88.2K ﹤0.01% 1878
2022
Q3
$1.4M Buy
107,073
+58,157
+119% +$859K ﹤0.01% 1693
2022
Q2
$685K Sell
48,916
-18,807
-28% -$251K ﹤0.01% 2138
2022
Q1
$1.01M Buy
67,723
+11,061
+20% +$151K ﹤0.01% 1937
2021
Q4
$768K Buy
56,662
+12,331
+28% +$174K ﹤0.01% 2195
2021
Q3
$657K Sell
44,331
-5,332
-11% -$90.1K ﹤0.01% 2094
2021
Q2
$905K Sell
49,663
-19,259
-28% -$343K ﹤0.01% 1821
2021
Q1
$1.2M Buy
68,922
+20,344
+42% +$358K ﹤0.01% 1498
2020
Q4
$844K Buy
48,578
+16,519
+52% +$264K ﹤0.01% 1813
2020
Q3
$445K Sell
32,059
-9,558
-23% -$140K ﹤0.01% 2021
2020
Q2
$601K Sell
41,617
-4,692
-10% -$61.7K ﹤0.01% 1715
2020
Q1
$505K Sell
46,309
-55,647
-55% -$1.03M ﹤0.01% 1780
2019
Q4
$2.16M Buy
101,956
+77,101
+310% +$1.73M ﹤0.01% 1468
2019
Q3
$570K Buy
24,855
+1,403
+6% +$29.9K ﹤0.01% 2257
2019
Q2
$461K Buy
23,452
+2,900
+14% +$56.5K ﹤0.01% 2102
2019
Q1
$400K Sell
20,552
-2,900
-12% -$55K ﹤0.01% 2206
2018
Q4
$387K Buy
23,452
+1,160
+5% +$23.4K ﹤0.01% 2201
2018
Q3
$515K Buy
22,292
+1,054
+5% +$23.9K ﹤0.01% 2011
2018
Q2
$454K Sell
21,238
-8,456
-28% -$165K ﹤0.01% 2105
2018
Q1
$524K Buy
29,694
+4,068
+16% +$71.7K ﹤0.01% 1915
2017
Q4
$481K Buy
25,626
+5,144
+25% +$102K ﹤0.01% 1514
2017
Q3
$450K Buy
20,482
+12,018
+142% +$272K ﹤0.01% 1759
2017
Q2
$204K Buy
+8,464
New +$215K ﹤0.01% 2048
2017
Q1
Sell
-17,056
Closed -$417K 2517
2016
Q4
$417K Buy
+17,056
New +$391K ﹤0.01% 1972
2016
Q3
Sell
-10,042
Closed -$207K 2109
2016
Q2
$207K Buy
+10,042
New +$209K ﹤0.01% 1924
2015
Q2
Sell
-23,712
Closed -$786K 2255
2015
Q1
$786K Buy
23,712
+4,174
+21% +$135K ﹤0.01% 1416
2014
Q4
$593K Sell
19,538
-19,263
-50% -$531K ﹤0.01% 1447
2014
Q3
$944K Sell
38,801
-174
-0.4% -$4.83K ﹤0.01% 1340
2014
Q2
$1.12M Sell
38,975
-2,548
-6% -$74K ﹤0.01% 1281
2014
Q1
$1.16M Buy
41,523
+1,553
+4% +$42.7K ﹤0.01% 1205
2013
Q4
$1.04M Buy
39,970
+515
+1% +$13.3K ﹤0.01% 1258
2013
Q3
$908K Buy
39,455
+19,203
+95% +$473K ﹤0.01% 1251
2013
Q2
$529K Buy
+20,252
New +$584K ﹤0.01% 1194

Other funds holding SBRA

HSBC Holdings's SBRA Position: Q1 2026 in Review

HSBC Holdings reduced its Sabra Healthcare REIT (SBRA) stake by 1.7% in Q1 2026, selling an estimated $174K and leaving 505,580 shares worth $9.73M. The position accounts for 0.01% of the portfolio, ranked #937.

HSBC Holdings first reported a position in SBRA in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.74M in Q4 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • HSBC Holdings held 505,580 shares of Sabra Healthcare REIT worth $9.73M as of Q1 2026.
  • HSBC Holdings sold 8,829 Sabra Healthcare REIT shares in Q1 2026, an estimated $174K.
  • Sabra Healthcare REIT made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #937 holding.
  • HSBC Holdings first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 46 quarters since.
  • HSBC Holdings's Sabra Healthcare REIT position peaked at $9.74M in Q4 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.